Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York

Eli S. Rosenberg, James M. Tesoriero, Elizabeth M. Rosenthal, Rakkoo Chung, Meredith A. Barranco, Linda M. Styer, Monica M. Parker, Shu-Yin John Leung, Johanne E. Morne, Danielle Greene, David R. Holtgrave, Dina Hoefer, Jessica Kumar, Tomoko Udo, Brad Hutton, Howard A. Zucker
doi: https://doi.org/10.1101/2020.05.25.20113050
Eli S. Rosenberg
1University at Albany School of Public Health, State University of New York, Rensselaer NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: erosenberg2@albany.edu
James M. Tesoriero
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth M. Rosenthal
1University at Albany School of Public Health, State University of New York, Rensselaer NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakkoo Chung
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meredith A. Barranco
1University at Albany School of Public Health, State University of New York, Rensselaer NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda M. Styer
3Wadsworth Center, New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica M. Parker
3Wadsworth Center, New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu-Yin John Leung
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanne E. Morne
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle Greene
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Holtgrave
1University at Albany School of Public Health, State University of New York, Rensselaer NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dina Hoefer
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Kumar
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoko Udo
1University at Albany School of Public Health, State University of New York, Rensselaer NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brad Hutton
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard A. Zucker
2New York State Department of Health, Albany NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance New York State (NYS) is an epicenter of the United States’ COVID-19 epidemic. Reliable estimates of cumulative incidence of SARS-CoV-2 infection in the population are critical to tracking the extent of transmission and informing policies, but US data are lacking, in part because societal closure complicates study conduct.

Objective To estimate the cumulative incidence of SARS-CoV-2 infection and percent of infections diagnosed in New York State, overall and by region, age, sex, and race and ethnicity.

Design Statewide cross-sectional seroprevalence study, conducted April 19-28, 2020.

Setting Grocery stores (n=99) located in 26 counties throughout NYS, which were essential businesses that remained open during a period of societal closure and attract a heterogenous clientele.

Participants Convenience sample of patrons ≥18 years and residing in New York State, recruited consecutively upon entering stores and via an in-store flyer.

Exposures Region (New York City, Westchester/Rockland, Long Island, Rest of New York State), age, sex, race and ethnicity.

Main Outcomes Primary outcome: cumulative incidence of SARS-CoV-2 infection, based on dry-blood spot (DBS) SARS-CoV-2 antibody reactivity; secondary outcome: percent of infections diagnosed.

Results Among 15,101 adults with suitable DBS specimens, 1,887 (12.5%) were reactive using a validated SARS-CoV-2 IgG microsphere immunoassay (sensitivity 87.9%, specificity 99.75%). Following post-stratification weighting on region, sex, age, and race and ethnicity and adjustment for assay characteristics, estimated cumulative incidence through March 29 was 14.0% (95% CI: 13.3-14.7%), corresponding to 2,139,300 (95% CI: 2,035,800-2,242,800) infection-experienced adults. Cumulative incidence was higher among Hispanic/Latino (29.2%, 95% CI: 27.2-31.2%), non-Hispanic black/African American (20.2% 95% CI, 18.1-22.3%), and non-Hispanic Asian (12.4%, 95% CI: 9.4-15.4%) adults than non-Hispanic white adults (8.1%, 95% CI: 7.4-8.7%, p<.0001). Cumulative incidence was highest in New York City (NYC) 22.7% (95% CI: 21.5%-24.0). Dividing diagnoses reported to NYS by estimated infection-experienced adults, an estimated 8.9% (95% CI: 8.4-9.3%) of infections were diagnosed, with those ≥55 years most likely to be diagnosed (11.3%, 95% CI: 10.4-12.2%).

Conclusions and Relevance Over 2 million adults were infected through late March 2020, with substantial variations by subpopulations. As this remains below herd immunity thresholds, monitoring, testing, and contact tracing remain essential public health strategies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

New York State Department of Health IRB approved this study

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are not publicly available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 29, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Eli S. Rosenberg, James M. Tesoriero, Elizabeth M. Rosenthal, Rakkoo Chung, Meredith A. Barranco, Linda M. Styer, Monica M. Parker, Shu-Yin John Leung, Johanne E. Morne, Danielle Greene, David R. Holtgrave, Dina Hoefer, Jessica Kumar, Tomoko Udo, Brad Hutton, Howard A. Zucker
medRxiv 2020.05.25.20113050; doi: https://doi.org/10.1101/2020.05.25.20113050
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Eli S. Rosenberg, James M. Tesoriero, Elizabeth M. Rosenthal, Rakkoo Chung, Meredith A. Barranco, Linda M. Styer, Monica M. Parker, Shu-Yin John Leung, Johanne E. Morne, Danielle Greene, David R. Holtgrave, Dina Hoefer, Jessica Kumar, Tomoko Udo, Brad Hutton, Howard A. Zucker
medRxiv 2020.05.25.20113050; doi: https://doi.org/10.1101/2020.05.25.20113050

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8796)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (396)
  • Infectious Diseases (except HIV/AIDS) (10577)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1762)
  • Nursing (104)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (966)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3992)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)